These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7543997)

  • 1. Attitudes to prenatal screening, diagnosis and research among pregnant women who accept or decline an alpha-fetoprotein test.
    Jørgensen FS
    Prenat Diagn; 1995 May; 15(5):419-29. PubMed ID: 7543997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attitude of pregnant women to prenatal screening].
    Jørgensen FS
    Ugeskr Laeger; 1996 Sep; 158(39):5447-52. PubMed ID: 8928256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's opinions on the offer and use of prenatal diagnosis.
    Tymstra TJ; Bajema C; Beekhuis JR; Mantingh A
    Prenat Diagn; 1991 Dec; 11(12):893-8. PubMed ID: 1725210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnant women's attitudes for accepting or declining a serum-alpha-fetoprotein test.
    Sandén ML; Bjurulf P
    Scand J Soc Med; 1988; 16(4):265-71. PubMed ID: 2466331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant women's attitudes and knowledge in relation to access to serum-alpha-fetoprotein test.
    Sandén ML; Bjurulf P
    Scand J Soc Med; 1988; 16(4):197-204. PubMed ID: 2466330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness and use of prenatal diagnosis among Greek women: a national survey.
    Mavrou A; Metaxotou C; Trichopoulos D
    Prenat Diagn; 1998 Apr; 18(4):349-55. PubMed ID: 9602481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining an alpha-fetoprotein test in pregnancy, why and who?
    Jørgensen FS
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):3-11. PubMed ID: 7531936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's attitudes to screening for neural tube defects.
    Bennett MJ; Gau GS; Gau DW
    Br J Obstet Gynaecol; 1980 May; 87(5):370-1. PubMed ID: 6155931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal genetic testing in Japan.
    Matsuda I; Suzumori K
    Community Genet; 2000; 3(1):12-6. PubMed ID: 12528736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland.
    Heikkilä A; Ryynänen M; Kirkinen P; Saarikoski S
    Fetal Diagn Ther; 1997; 12(2):93-6. PubMed ID: 9218949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary approaches to prenatal diagnosis.
    Kuller JA; Laifer SA
    Am Fam Physician; 1995 Dec; 52(8):2277-83, 2285-6. PubMed ID: 7484721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity, bioethics, and prenatal diagnosis: the amniocentesis decisions of Mexican-origin women and their partners.
    Browner CH; Preloran HM; Cox SJ
    Am J Public Health; 1999 Nov; 89(11):1658-66. PubMed ID: 10553385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On what grounds do women participate in prenatal screening?
    Santalahti P; Aro AR; Hemminki E; Helenius H; Ryynänen M
    Prenat Diagn; 1998 Feb; 18(2):153-65. PubMed ID: 9516017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The choices women make about prenatal diagnosis.
    Evans MI; Pryde PG; Evans WJ; Johnson MP
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):70-80. PubMed ID: 11653025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of women of childbearing age towards prenatal diagnosis in southeastern France.
    Julian-Reynier C; Macquart-Moulin G; Moatti JP; Loundou A; Aurran Y; Chabal F; Aymé S
    Prenat Diagn; 1993 Jul; 13(7):613-27. PubMed ID: 8415427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening and pregnant women's attitudes toward the abortion of defective fetuses.
    Faden RR; Chwalow AJ; Quaid K; Chase GA; Lopes C; Leonard CO; Holtzman NA
    Am J Public Health; 1987 Mar; 77(3):288-90. PubMed ID: 3812832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.